Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Reversal of Locked-in Syndrome with Anticoagulation, Induced Hypertension, and Intravenous t-PA
    K.E. Wartenberg, MD, N.S. Janjua, MD, S.A. Mayer, MD and P. Meyers, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S62;
  • You have access
    Carotid stenting in high-risk patients: Design and rationale of the SAPPHIRE trial
    Jay S. Yadav, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S45-S46;
  • You have access
    Medical management of intracranial atherosclerosis: Current state of the art
    Cathy A. Sila, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S47-S49;
  • You have access
    Multimodal monitoring in neurocritical care
    Michael A. De Georgia, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S16-S17;
  • You have access
    Fatal Arrhythmia in an Anxious Patient During Recovery from Lateral Medullary Infarction
    Julius Gene Lattore, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S61;
  • You have access
    How to use statins in patients with chronic liver disease
    Mark W. Russo, MD and Ira M. Jacobson, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1) 58-62;

    Statin-induced liver disease is uncommon, and there is little evidence to suggest that it is more likely in patients with chronic liver disease.

  • You have access
    Integrative Monitoring Methods in Neurocritical Care
    A. Deogaonkar, A. Vander Kouwe, K. Horning, R. Burgess and M. De Georgia
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S63;
  • You have access
    The development of neurologic intensive care
    Allan H. Ropper, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S4-S5;
  • You have access
    New fibrinolytic agents for MI: As effective as current agents, but easier to administer
    Keith Ellis, MD and Sorin Brener, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1) 20-37;

    Ease of administration is important. Many patients who might be candidates for fibrinolytic therapy are not getting it, and the complicated regimens of the current drugs may partly account for their underuse.

  • You have access
    Anticoagulation for stroke prevention: Yes, no, maybe
    J.P. Mohr, MD
    Cleveland Clinic Journal of Medicine January 2004, 71 (1 suppl 1) S52-S56;

Pages

  • Previous
  • Next
  • 1
  • …
  • 355
  • 356
  • 357
  • 358
  • 359
  • 360
  • 361
  • 362
  • 363
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2026 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire